Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shionogi Co-promotes Flu Diagnostic Kit Along With Peramivir

This article was originally published in PharmAsia News

Executive Summary

Osaka-based Shionogi started co-promoting a flu virus diagnostic kit developed by Tokyo-based Mizuho Medy in Japan. The Quick Chaser Flu A,B can quickly detect the flu virus and will be marketed along with Shionogi's newly launched flu drug Rapiacta (peramivir) injection. The co-promotion deal will enable Shionogi to provide flu patients with a full line of services from detection to treatment. The diagnostic kit is priced at ¥11,000 for 10 uses. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC074247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel